Joint Pain Forum – News you can use!
Firm
gets green light to develop rainforest-based pharmaceuticals
Monday, April 9, 2007
ABC ON-line
A north Queensland company hopes to
develop treatments for cancer, arthritis and Alzheimer's disease after
being granted permission to collect rainforest material under new
biodiversity laws.
The chief executive officer of EcoBiotics,
Dr Victoria Gordon, says the agreement is an Australian first and will
allow the company to replicate natural rainforest resources for
medicinal purposes by developing pharmaceutical products from natural
resources in rainforests.
She says the company is conducting
pre-clinical trials on new drugs, but the focus of the research is on
treatment for solid cancerous tumours.
"Our focus
area at the moment is anti-cancer, particularly solid tumour,
anti-inflammatory for applications in things like rheumatoid arthritis,
antibiotics, we have a number of new drugs in development at the
moment," she said.
Dr Gordon says the company will harvest
plants and fungi in a search for new chemicals that can be developed
into drugs used to treat solid tumours and central nervous system
illnesses.
"EcoBiotics is concentrating in the big
problem areas with things like prostate cancer, breast cancer, the
multiple resistant bacteria," she said.
"We're looking for some really new types
of antibiotics and moving into the central nervous system problems like
Alzheimer's."
MEMBERS
AREA
| Site
Map | CONTACT
US
Privacy
| Terms
| 
